Latest Lycopodium (ASX:LYL) News

Lycopodium Limited reported a solid FY26 with $377.5 million revenue, a slight profit dip, and a 69% dividend hike, while setting sights on accelerated growth in the Americas.

Lycopodium Limited has won a A$37 million EPCM contract to develop a new silver oxide processing plant at Bolivia’s San Cristóbal Mine, aiming to boost silver production alongside existing operations.

Lycopodium has secured a A$93 million EPCM contract to expand Artemis Gold’s Blackwater Mine in Canada, boosting the mine’s throughput capacity to one of the largest in the country.

Big moves came from small and mid-cap names tied to drilling, project studies and fresh funding. Healthcare, mining and takeover stocks all had a busy week, but not every strong announcement held its gains.

A handful of small-cap names posted big weekly swings, but the bigger story was a flood of new studies, resource upgrades and funding deals across gold, rare earths and battery materials. Investors chased scale and near-term production, while several raisings and gap-down reopenings showed how quickly early enthusiasm can fade.

Lycopodium Limited has landed a A$196 million engineering and construction management contract for Resolute Mining’s Doropo Gold Project, marking a major expansion in West Africa.

Gold names split cleanly this week: one stock rocketed on tangible production progress, while another cratered as selling overwhelmed a big plan. Critical minerals kept drawing attention, but several gap-ups didn’t hold once early buyers took profits.

Lycopodium Limited has landed a major A$118 million contract to engineer and supply the Tulu Kapi Gold Project in Ethiopia, marking a significant step toward full gold production by mid-2028.

Lycopodium Limited reports strong half-year results for 1H FY26, driven by increased project delivery and strategic expansion into the Americas. The company updates its full-year guidance amid a robust pipeline across gold, copper, and critical minerals.

Lycopodium Limited has addressed ASX concerns over delayed director interest disclosures, attributing the lapse to an administrative oversight while reaffirming its compliance policies.

Lycopodium Limited projects steady growth for FY26 with revenue guidance of $390-$410 million, underpinned by strong project momentum and the strategic SAXUM acquisition expanding its footprint in the Americas.

Lycopodium Limited delivered robust FY25 financial results, hitting the top end of guidance with $339.6 million revenue and $42.2 million net profit. The company’s strategic SAXUM acquisition broadens its footprint in the Americas, positioning it well for growth in critical minerals and clean energy sectors.